Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.

IF 0.2 4区 医学 Q4 Medicine
生殖医学杂志 Pub Date : 2016-09-01
Baohua Li, Xiaoyun Wan, Yun Liang, Bingjian Lu, Weiguo Lu
{"title":"Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.","authors":"Baohua Li,&nbsp;Xiaoyun Wan,&nbsp;Yun Liang,&nbsp;Bingjian Lu,&nbsp;Weiguo Lu","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the clinical characteristics and outcomes of patients with re-recurrent gestational trophoblastic neoplasia (GTN).</p><p><strong>Study design: </strong>A total of 547 patients with typical GTN at our institution from 2000-2012 were enrolled in this retrospective study. Of 547 cases, 29 relapsed after initial remission, and 7 of 29 patients with recurrent GTN had repeat relapses. The detailed clinical charac- teristics of patients with re-recurrent GTN were eval- uated.</p><p><strong>Results: </strong>The recurrence and re-recurrence rates in 547 patients with GTN were 5.3% and 24%, respective- ly. In 7 patients with re-recurrent GTN the mean age was 43 years. The mean level of serum [-hCG before each treatment was 11,405 IU/L. The mean time interval from last treatment to recurrence was 38 months. All 7 patients received first- and second-line chemotherapy, and 4 of them required salvage chemotherapy. The total number of chemotherapy courses administered was 137 (mean= 6). In conjunction with chemotherapy, surgery was performed in all 7 patients. After final treatment 7 patients had a median follow-up of 20 months. Although 1 died secondary to disease progression, the remaining 6 achieved serologic complete remission.</p><p><strong>Conclusion: </strong>Our anal- ysis suggests that surgical intervention and intensive chemotherapy could be equally important for the treatment of . the patients with re-recurrent GTN. Be- cause the patients have a favorable prognosis, the principles of treatment for re-recurrent GTN should strive to cure.disease rather than simply relieve the symptoms of disease or delay the time of relapse.</p>","PeriodicalId":50063,"journal":{"name":"生殖医学杂志","volume":"61 9-10","pages":"494-502"},"PeriodicalIF":0.2000,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"生殖医学杂志","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To analyze the clinical characteristics and outcomes of patients with re-recurrent gestational trophoblastic neoplasia (GTN).

Study design: A total of 547 patients with typical GTN at our institution from 2000-2012 were enrolled in this retrospective study. Of 547 cases, 29 relapsed after initial remission, and 7 of 29 patients with recurrent GTN had repeat relapses. The detailed clinical charac- teristics of patients with re-recurrent GTN were eval- uated.

Results: The recurrence and re-recurrence rates in 547 patients with GTN were 5.3% and 24%, respective- ly. In 7 patients with re-recurrent GTN the mean age was 43 years. The mean level of serum [-hCG before each treatment was 11,405 IU/L. The mean time interval from last treatment to recurrence was 38 months. All 7 patients received first- and second-line chemotherapy, and 4 of them required salvage chemotherapy. The total number of chemotherapy courses administered was 137 (mean= 6). In conjunction with chemotherapy, surgery was performed in all 7 patients. After final treatment 7 patients had a median follow-up of 20 months. Although 1 died secondary to disease progression, the remaining 6 achieved serologic complete remission.

Conclusion: Our anal- ysis suggests that surgical intervention and intensive chemotherapy could be equally important for the treatment of . the patients with re-recurrent GTN. Be- cause the patients have a favorable prognosis, the principles of treatment for re-recurrent GTN should strive to cure.disease rather than simply relieve the symptoms of disease or delay the time of relapse.

7例再发妊娠滋养细胞瘤的临床特点及预后分析。
目的:分析再发妊娠滋养细胞瘤(GTN)患者的临床特点及转归。研究设计:本研究纳入我院2000-2012年547例典型GTN患者。547例患者中,29例初次缓解后复发,29例复发性GTN患者中有7例复发。对再发GTN患者的详细临床特征进行了评价。结果:547例GTN患者的复发率为5.3%,再复发率为24%。7例再发GTN患者平均年龄43岁。每次治疗前血清[-hCG]平均水平为11,405 IU/L。从最后一次治疗到复发的平均时间间隔为38个月。7例患者均接受了一线和二线化疗,其中4例患者需要补救性化疗。总化疗疗程为137次(平均6次)。在化疗的同时,7例患者均行手术治疗。最终治疗后,7例患者中位随访时间为20个月。1例因疾病进展而死亡,其余6例血清学完全缓解。结论:我们的肛门分析表明,手术干预和强化化疗对治疗肛瘘同样重要。再发GTN患者。由于患者预后良好,再发GTN的治疗原则应力求治愈。而不是单纯缓解疾病症状或延缓疾病复发的时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
生殖医学杂志
生殖医学杂志 医学-妇产科学
自引率
0.00%
发文量
6427
审稿时长
6-12 weeks
期刊介绍: The Journal of Reproductive Medicine® has been the essential tool of Obstetricians and Gynecologists since 1968. As a highly regarded professional journal and the official periodical of six medical associations, JRM® brings timely and relevant information on the latest procedures and advances in the field of reproductive medicine. Published bimonthly, JRM® contains peer-reviewed articles and case reports submitted by top specialists. Common topics include research, clinical practice, and case reports related to general obstetrics and gynecology, infertility, female cancers, gynecologic surgery, contraception, and medical education.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信